| タイトル |
Risedronate therapy in patients with mild-to-moderate chronic kidney disease with osteoporosis: post-hoc analysis of data from the risedronate phase III clinical trials
|
| 著者 |
Shigematsu Takashi
Muraoka Ryoichi
Nishizawa Yoshiki
|
| 収録物名 |
BMC NEPHROLOGY
|
| 巻 | 18 |
| 収録物識別子 |
ISSN 1471-2369
|
| 主題 | |
| 言語 |
英語
|
| 資源タイプ | 学術雑誌論文 |
| 出版者 |
BIOMED CENTRAL LTD
|
| 発行日 | 2017-02-15 |
| アクセス権 | メタデータのみ |
| 関連情報 |
[DOI] 10.1186/s12882-017-0478-9
[PMID] 28201994
|
| 備考 | This study was supported by the Joint Development Program of EA Pharma Co., Ltd. and Takeda Pharmaceutical Co., Ltd. Funding for writing/editorial support was provided by EA Pharma Co., Ltd. |
